Russell Investments Group
SCMP

Russell Investments Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Russell Investments Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-16,409
Closed -$295K – 3103
2017
Q4 		$295K Buy
16,409
+9,372
+133% +$115K ﹤0.01% 2575
2017
Q3 		$83K Sell
7,037
-8,058
-53% -$90.4K ﹤0.01% 2799
2017
Q2 		$159K Sell
15,095
-6,434
-30% -$65.6K ﹤0.01% 2730
2017
Q1 		$237K Sell
21,529
-19,383
-47% -$225K ﹤0.01% 2659
2016
Q4 		$555K Buy
+40,912
New +$571K ﹤0.01% 2428

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Russell Investments Group's SCMP Position: Q1 2018 in Review

Russell Investments Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 16,409 shares — an estimated $295K sold.

Russell Investments Group first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $555K in Q4 2016. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Russell Investments Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Russell Investments Group sold 16,409 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $295K.
  • Russell Investments Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
  • Russell Investments Group's Sucampo Pharmaceuticals, Inc. position peaked at $555K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Russell Investments Group's 13F filing for Q1 2018, filed 11 May 2018.